Covered recipient · General Payments record
ADRIAN VAZQUEZ
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$24,441.13
- Reported across 176 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $646.45 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $396.81 | 23 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $74.15 | 3 |
| ABBVIE INC. | $63.81 | 3 |
| E.R. Squibb & Sons, L.L.C. | $46.30 | 2 |
| Janssen Biotech, Inc. | $41.54 | 2 |
| Celgene Corporation | $23.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.31 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106275580 | CMS |
| ABBVIE INC. | $22.75 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106275582 | CMS |
| ABBVIE INC. | $25.75 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106275584 | CMS |
| Amgen Inc. | $26.93 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732423 | CMS |
| Amgen Inc. | $21.44 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732421 | CMS |
| Amgen Inc. | $12.17 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732447 | CMS |
| Amgen Inc. | $10.08 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732425 | CMS |
| Amgen Inc. | $15.62 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732449 | CMS |
| Amgen Inc. | $22.68 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732451 | CMS |
| Amgen Inc. | $11.34 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732453 | CMS |
| Amgen Inc. | $8.60 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732455 | CMS |
| Amgen Inc. | $13.98 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732427 | CMS |
| Amgen Inc. | $22.80 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732429 | CMS |
| Amgen Inc. | $16.86 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732457 | CMS |
| Amgen Inc. | $14.73 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732459 | CMS |
| Amgen Inc. | $21.97 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732461 | CMS |
| Amgen Inc. | $16.45 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117405912 | CMS |
| Amgen Inc. | $11.82 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732463 | CMS |
| Amgen Inc. | $16.99 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732431 | CMS |
| Amgen Inc. | $26.85 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732433 | CMS |
| Amgen Inc. | $21.93 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732435 | CMS |
| Amgen Inc. | $13.96 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732437 | CMS |
| Amgen Inc. | $27.13 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732439 | CMS |
| Amgen Inc. | $24.58 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732441 | CMS |
| Amgen Inc. | $10.67 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732443 | CMS |
| Amgen Inc. | $7.23 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111732445 | CMS |
| Celgene Corporation | $23.84 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101193089 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.25 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101832879 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.05 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101832913 | CMS |
| Janssen Biotech, Inc. | $20.72 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078815912 | CMS |
| Janssen Biotech, Inc. | $20.82 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078816388 | CMS |
| Novartis Pharmaceuticals Corporation | $29.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087416916 | CMS |
| Novartis Pharmaceuticals Corporation | $22.40 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087416920 | CMS |
| Novartis Pharmaceuticals Corporation | $22.75 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087416922 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.